Ipamorelin versus GHRP-2
GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth hormone release, producing larger GH pulses at equivalent doses. But GHRP-2 stil
This comparison does not assign a generated winner or score.
- GHRP-2 was developed as an improvement over GHRP-6, and it is in some ways. The hunger effect is reduced compared to GHRP-6, though still present. GHRP-2 is more potent for growth hormone release, producing larger GH pulses at equivalent doses.
- But GHRP-2 still raises cortisol and prolactin, though to a lesser degree than GHRP-6. It still has effects on blood sugar and has been associated with more concerning adverse events in some clinical contexts. The improved potency comes with a side effect profile that remains significantly more problematic than ipamorelin.
- Ipamorelin sacrifices some of the raw GH-boosting power for a much cleaner experience. For most applications, this tradeoff is worthwhile. The difference in GH release is not dramatic, but the difference in side effects is substantial.